Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway

Susan Ingram, Christopher W. Vaughan, Elena E. Bagley, Mark Connor, MacDonald J. Christie

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Chronic morphine administration induces adaptations in neurons resulting in opioid tolerance and dependence. Functional studies have implicated a role for the periaqueductal gray area (PAG) in the expression of many signs of opioid withdrawal, but the cellular mechanisms are not fully understood. This study describes an increased efficacy, rather than tolerance, of opioid agonists at μ-receptors on GABAergic (but not glutamatergic) nerve terminals in PAG after chronic morphine treatment. Opioid withdrawal enhanced the amplitudes of electrically evoked inhibitory synaptic currents mediated by GABA(A) receptors and increased the frequency of spontaneous miniature GABAergic synaptic currents. These effects were not blocked by 4- aminopyridine or dendrotoxin, although both Kv channel blockers abolish acute opioid presynaptic inhibition of GABA release in PAG. Instead, the withdrawal-induced increases were blocked by protein kinase A inhibitors and occluded by metabolically stable cAMP analogs, which do not prevent acute opioid actions. These findings indicate that opioid dependence induces efficacious coupling of μ-receptors to presynaptic inhibition in GABAergic nerve terminals via adenylyl cyclase- and protein kinase A-dependent processes in PAG. The potential role of these adaptations in expression of withdrawal behavior was supported by inhibition of enhanced GABAergic synaptic transmission by the α2 adrenoceptor agonist clonidine. These findings provide a cellular mechanism that is consistent with other studies demonstrating attenuated opioid withdrawal behavior after injections of protein kinase A inhibitors into PAG and suggest a general mechanism whereby opioid withdrawal may enhance synaptic neurotransmission.

Original languageEnglish (US)
Pages (from-to)10269-10276
Number of pages8
JournalJournal of Neuroscience
Volume18
Issue number24
StatePublished - Dec 15 1998
Externally publishedYes

Fingerprint

Opioid Analgesics
Signal Transduction
Periaqueductal Gray
Cyclic AMP-Dependent Protein Kinases
Protein Kinase Inhibitors
Synaptic Transmission
Morphine
Presynaptic Receptors
4-Aminopyridine
Clonidine
GABA-A Receptors
Adenylyl Cyclases
gamma-Aminobutyric Acid
Adrenergic Receptors
Neurons
Injections

Keywords

  • Adenylyl cyclase
  • Opioid dependence
  • Opioid efficacy
  • Opioid withdrawal
  • Periaqueductal gray
  • Protein kinase A
  • Sensitization
  • Synaptic plasticity

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Ingram, S., Vaughan, C. W., Bagley, E. E., Connor, M., & Christie, M. J. (1998). Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. Journal of Neuroscience, 18(24), 10269-10276.

Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. / Ingram, Susan; Vaughan, Christopher W.; Bagley, Elena E.; Connor, Mark; Christie, MacDonald J.

In: Journal of Neuroscience, Vol. 18, No. 24, 15.12.1998, p. 10269-10276.

Research output: Contribution to journalArticle

Ingram, S, Vaughan, CW, Bagley, EE, Connor, M & Christie, MJ 1998, 'Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway', Journal of Neuroscience, vol. 18, no. 24, pp. 10269-10276.
Ingram, Susan ; Vaughan, Christopher W. ; Bagley, Elena E. ; Connor, Mark ; Christie, MacDonald J. / Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. In: Journal of Neuroscience. 1998 ; Vol. 18, No. 24. pp. 10269-10276.
@article{1f25b11a4f6c4448a403d694cea96743,
title = "Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway",
abstract = "Chronic morphine administration induces adaptations in neurons resulting in opioid tolerance and dependence. Functional studies have implicated a role for the periaqueductal gray area (PAG) in the expression of many signs of opioid withdrawal, but the cellular mechanisms are not fully understood. This study describes an increased efficacy, rather than tolerance, of opioid agonists at μ-receptors on GABAergic (but not glutamatergic) nerve terminals in PAG after chronic morphine treatment. Opioid withdrawal enhanced the amplitudes of electrically evoked inhibitory synaptic currents mediated by GABA(A) receptors and increased the frequency of spontaneous miniature GABAergic synaptic currents. These effects were not blocked by 4- aminopyridine or dendrotoxin, although both Kv channel blockers abolish acute opioid presynaptic inhibition of GABA release in PAG. Instead, the withdrawal-induced increases were blocked by protein kinase A inhibitors and occluded by metabolically stable cAMP analogs, which do not prevent acute opioid actions. These findings indicate that opioid dependence induces efficacious coupling of μ-receptors to presynaptic inhibition in GABAergic nerve terminals via adenylyl cyclase- and protein kinase A-dependent processes in PAG. The potential role of these adaptations in expression of withdrawal behavior was supported by inhibition of enhanced GABAergic synaptic transmission by the α2 adrenoceptor agonist clonidine. These findings provide a cellular mechanism that is consistent with other studies demonstrating attenuated opioid withdrawal behavior after injections of protein kinase A inhibitors into PAG and suggest a general mechanism whereby opioid withdrawal may enhance synaptic neurotransmission.",
keywords = "Adenylyl cyclase, Opioid dependence, Opioid efficacy, Opioid withdrawal, Periaqueductal gray, Protein kinase A, Sensitization, Synaptic plasticity",
author = "Susan Ingram and Vaughan, {Christopher W.} and Bagley, {Elena E.} and Mark Connor and Christie, {MacDonald J.}",
year = "1998",
month = "12",
day = "15",
language = "English (US)",
volume = "18",
pages = "10269--10276",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "24",

}

TY - JOUR

T1 - Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway

AU - Ingram, Susan

AU - Vaughan, Christopher W.

AU - Bagley, Elena E.

AU - Connor, Mark

AU - Christie, MacDonald J.

PY - 1998/12/15

Y1 - 1998/12/15

N2 - Chronic morphine administration induces adaptations in neurons resulting in opioid tolerance and dependence. Functional studies have implicated a role for the periaqueductal gray area (PAG) in the expression of many signs of opioid withdrawal, but the cellular mechanisms are not fully understood. This study describes an increased efficacy, rather than tolerance, of opioid agonists at μ-receptors on GABAergic (but not glutamatergic) nerve terminals in PAG after chronic morphine treatment. Opioid withdrawal enhanced the amplitudes of electrically evoked inhibitory synaptic currents mediated by GABA(A) receptors and increased the frequency of spontaneous miniature GABAergic synaptic currents. These effects were not blocked by 4- aminopyridine or dendrotoxin, although both Kv channel blockers abolish acute opioid presynaptic inhibition of GABA release in PAG. Instead, the withdrawal-induced increases were blocked by protein kinase A inhibitors and occluded by metabolically stable cAMP analogs, which do not prevent acute opioid actions. These findings indicate that opioid dependence induces efficacious coupling of μ-receptors to presynaptic inhibition in GABAergic nerve terminals via adenylyl cyclase- and protein kinase A-dependent processes in PAG. The potential role of these adaptations in expression of withdrawal behavior was supported by inhibition of enhanced GABAergic synaptic transmission by the α2 adrenoceptor agonist clonidine. These findings provide a cellular mechanism that is consistent with other studies demonstrating attenuated opioid withdrawal behavior after injections of protein kinase A inhibitors into PAG and suggest a general mechanism whereby opioid withdrawal may enhance synaptic neurotransmission.

AB - Chronic morphine administration induces adaptations in neurons resulting in opioid tolerance and dependence. Functional studies have implicated a role for the periaqueductal gray area (PAG) in the expression of many signs of opioid withdrawal, but the cellular mechanisms are not fully understood. This study describes an increased efficacy, rather than tolerance, of opioid agonists at μ-receptors on GABAergic (but not glutamatergic) nerve terminals in PAG after chronic morphine treatment. Opioid withdrawal enhanced the amplitudes of electrically evoked inhibitory synaptic currents mediated by GABA(A) receptors and increased the frequency of spontaneous miniature GABAergic synaptic currents. These effects were not blocked by 4- aminopyridine or dendrotoxin, although both Kv channel blockers abolish acute opioid presynaptic inhibition of GABA release in PAG. Instead, the withdrawal-induced increases were blocked by protein kinase A inhibitors and occluded by metabolically stable cAMP analogs, which do not prevent acute opioid actions. These findings indicate that opioid dependence induces efficacious coupling of μ-receptors to presynaptic inhibition in GABAergic nerve terminals via adenylyl cyclase- and protein kinase A-dependent processes in PAG. The potential role of these adaptations in expression of withdrawal behavior was supported by inhibition of enhanced GABAergic synaptic transmission by the α2 adrenoceptor agonist clonidine. These findings provide a cellular mechanism that is consistent with other studies demonstrating attenuated opioid withdrawal behavior after injections of protein kinase A inhibitors into PAG and suggest a general mechanism whereby opioid withdrawal may enhance synaptic neurotransmission.

KW - Adenylyl cyclase

KW - Opioid dependence

KW - Opioid efficacy

KW - Opioid withdrawal

KW - Periaqueductal gray

KW - Protein kinase A

KW - Sensitization

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=0032535012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032535012&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 10269

EP - 10276

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 24

ER -